![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » SUN PHARMA TO MARKET GLEEVEC'S GENERIC VERSION
SUN PHARMA TO MARKET GLEEVEC'S GENERIC VERSION
The $2.2 billion anti-cancer drug Gleevec is about to face stiff competition from Indian shores. Mumbai-based Sun Pharma is among the first generic firms to have approached the US Food and Drug Administration to market a generic version in US market. India Business (http://timesofindia.indiatimes.com/articleshow/1927836.cms)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct